BR112014009265A2 - micelas de proteína de soro do leite contra atrofia muscular e sarcopenia - Google Patents

micelas de proteína de soro do leite contra atrofia muscular e sarcopenia

Info

Publication number
BR112014009265A2
BR112014009265A2 BR112014009265A BR112014009265A BR112014009265A2 BR 112014009265 A2 BR112014009265 A2 BR 112014009265A2 BR 112014009265 A BR112014009265 A BR 112014009265A BR 112014009265 A BR112014009265 A BR 112014009265A BR 112014009265 A2 BR112014009265 A2 BR 112014009265A2
Authority
BR
Brazil
Prior art keywords
whey protein
protein micelles
sarcopenia
muscle atrophy
against muscle
Prior art date
Application number
BR112014009265A
Other languages
English (en)
Other versions
BR112014009265A8 (pt
Inventor
Moore Daniel
Breuille Denis
Pouteau Etienne
Jean René Bovetto Lionel
Stellingwerff Trent
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47040743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014009265(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112014009265A2 publication Critical patent/BR112014009265A2/pt
Publication of BR112014009265A8 publication Critical patent/BR112014009265A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2210/00—Physical treatment of dairy products
    • A23C2210/40—Microencapsulation; Encapsulation of particles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)

Abstract

abstract the present invention relates to whey protein micelles for use in the treatment and/or prevention of a condition linked to a reduced concentration of plasma amino acids in a patient. a further aspect of the invention is a meal replacement comprising whey protein micelles. tradução do resumo resumo patente de invenção: "micelas de proteína de soro do leite contra atrofia muscular e sarcopenia". a presente invenção refere-se a micelas de proteína de soro do leite para uso no tratamento e/ou prevenção de uma afecção ligada a uma concentração reduzida de aminoácidos de plasma em um paciente. um aspecto adicional da invenção é uma substituto de refeição que compreende micelas de proteína de soro do leite.
BR112014009265A 2011-10-21 2012-10-19 micelas de proteína de soro do leite contra atrofia muscular e sarcopenia BR112014009265A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11186143.1A EP2583563A1 (en) 2011-10-21 2011-10-21 Whey protein micelles against muscle atrophy and sarcopenia
PCT/EP2012/070714 WO2013057230A1 (en) 2011-10-21 2012-10-19 Whey protein micelles against muscle atrophy and sarcopenia

Publications (2)

Publication Number Publication Date
BR112014009265A2 true BR112014009265A2 (pt) 2017-06-13
BR112014009265A8 BR112014009265A8 (pt) 2017-06-20

Family

ID=47040743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009265A BR112014009265A8 (pt) 2011-10-21 2012-10-19 micelas de proteína de soro do leite contra atrofia muscular e sarcopenia

Country Status (9)

Country Link
US (2) US20140249078A1 (pt)
EP (3) EP2583563A1 (pt)
JP (1) JP2014534203A (pt)
CN (1) CN103945711B (pt)
AU (1) AU2012324884B2 (pt)
BR (1) BR112014009265A8 (pt)
CA (1) CA2853167C (pt)
ES (2) ES2683176T3 (pt)
WO (1) WO2013057230A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2768758T3 (es) 2014-11-19 2020-06-23 Nestle Sa Complejos de micelas de proteína de suero de leche y síntesis de proteínas musculares
US10744100B2 (en) 2015-11-17 2020-08-18 Societe Des Produits Nestle S.A. Compositions and methods using a polyphenol for musculoskeletal health
JP6859336B2 (ja) * 2015-11-17 2021-04-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 骨格筋の健康のためポリフェノールを使用する組成物及び方法
AU2016358033A1 (en) * 2015-11-20 2018-04-12 Société des Produits Nestlé S.A. Methods using whey protein to improve or maintain muscle quality
EP3468389A1 (en) 2016-06-10 2019-04-17 Nestec S.A. Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein
BR112018073930B1 (pt) * 2016-06-10 2022-08-30 Société des Produits Nestlé S.A. Composições enterais com alto teor de proteína esterilizada por calor contendo proteína de soro de leite que compreende micelas de proteína de soro de leite e uma fonte de caseína, seu processo de preparação, e usos de uma fonte de proteína e de micelas de proteína de soro de leite em combinação com uma fonte de caseína
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018149869A1 (en) 2017-02-17 2018-08-23 Arla Foods Amba High-protein, acidified, liquid dairy product having a reduced viscosity, method of producing it, and related ingredients
JPWO2018164251A1 (ja) * 2017-03-10 2020-01-09 株式会社明治 体力向上用組成物
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
CN111315239A (zh) * 2017-11-21 2020-06-19 雀巢产品有限公司 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
PT1148791E (pt) 1998-10-16 2003-04-30 Nestle Sa Materia proteica de digestao lenta e sua utilizacao
DE19964370B4 (de) 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
ES2411029T3 (es) * 2005-01-18 2013-07-04 Desarrollos Especiales De Sistemas De Anclaje, S.A. Grapa para atar tallos o ramas de plantas a una cuerda, palo u otro elemento guía
ATE524073T1 (de) 2006-03-27 2011-09-15 Nestec Sa Molkenprotein micellen
ES2365246T3 (es) * 2006-03-27 2011-09-27 Nestec S.A. Vehículo de proteína del suero de la leche para el suministro de un agente activo.
WO2008086538A1 (en) 2007-01-14 2008-07-17 Glanbia Plc Branched chain amino acid chelate
CN103005464B (zh) * 2008-10-17 2015-01-07 雀巢产品技术援助有限公司 乳清蛋白组合物、方法及用途
US20120195873A1 (en) * 2009-07-20 2012-08-02 Nestec S.A. Methods of attenuating the loss of functional status
WO2011078654A1 (en) * 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
BR112012023025B1 (pt) * 2010-03-12 2021-06-01 Société des Produits Nestlé S.A. Composição nutricional, e método para mascarar sabores estranhos de leucina na mesma
MX2013012228A (es) * 2011-04-18 2013-12-06 Nestec Sa Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas.
EP2583564A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for improving insulin profile in diabetic patients
EP2583565A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for enhancing energy expenditure and satiety
PT2583566E (pt) * 2011-10-21 2015-11-13 Nestec Sa Micelas de proteína de soro de leite para aumentar a massa muscular e desempenho
ES2768758T3 (es) * 2014-11-19 2020-06-23 Nestle Sa Complejos de micelas de proteína de suero de leche y síntesis de proteínas musculares
EP3220752B1 (en) * 2014-11-19 2021-01-27 Société des Produits Nestlé S.A. Use of whey protein micelles and polysaccharides for improving insulin profile

Also Published As

Publication number Publication date
AU2012324884B2 (en) 2016-08-11
EP2768322A1 (en) 2014-08-27
EP3398454B1 (en) 2021-07-21
EP2583563A1 (en) 2013-04-24
BR112014009265A8 (pt) 2017-06-20
ES2683176T3 (es) 2018-09-25
JP2014534203A (ja) 2014-12-18
EP2768322B1 (en) 2018-05-30
US20140249078A1 (en) 2014-09-04
CN103945711B (zh) 2016-09-14
CA2853167A1 (en) 2013-04-25
AU2012324884A1 (en) 2014-05-01
CN103945711A (zh) 2014-07-23
WO2013057230A1 (en) 2013-04-25
ES2894296T3 (es) 2022-02-14
US20220072096A1 (en) 2022-03-10
EP3398454A1 (en) 2018-11-07
CA2853167C (en) 2020-06-02

Similar Documents

Publication Publication Date Title
BR112014009265A8 (pt) micelas de proteína de soro do leite contra atrofia muscular e sarcopenia
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
BR112013026539A2 (pt) composições nutricionais que têm a-hica e a-cetoglutarato e métodos de uso das mesmas
BR112012018256A8 (pt) método de tratamento de doença de parkinson
BR112014009418A2 (pt) macrociclos peptidomiméticos
NZ757815A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
BR112014008036A2 (pt) tratamento de rinite
IN2014KN02830A (pt)
NZ607189A (en) Materials and methods for improving gastrointestinal function
ES2721448T3 (es) GLYX-13 para uso en el tratamiento de enfermedad de Alzheimer, enfermedad de Parkinson y enfermedad de Huntington
BR112014009225A8 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
BR112012008238A2 (pt) métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais.
BR112013010556A2 (pt) métodos e composições adequadas para a promoção de uma pele saudável
BR112013031652A2 (pt) métodos de tratamento para doenças retinais
BR112013033008A8 (pt) composição farmacêutica líquida compreendendo nitisinona
CO6592101A2 (es) Metodos para tratar ulceras de pie de diabetico
BR112012015202A2 (pt) "iota - e/ou kappa-carrgenado junto com um inibidor da neuraminidase, método para o tratamento profilático ou terapêutico de um sintoma, condição ou doença, composição farmacêutica,e, kit de partes".
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
BR112014019399A2 (pt) métodos de tratamento da fibrose
WO2009140269A3 (en) Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
BR112015013708A2 (pt) polipeptídeo compreendendo uma proteína igf-1 humana, polinucleotídeo, composição farmacêutica e uso
MX2013006094A (es) Metodo para inhibir patogenos usando composicion nutricional.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/17 (2006.01), A23L 33/19 (2016.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]